The co-chairs of the National Oncologic PET Registry (NOPR) Working Group have requested a formal reconsideration of the Centers for Medicare & Medicaid Services (CMS) National Coverage Analyses on FDG-PET for oncologic indications. Specifically, they are requesting to end the remaining prospective data collection requirements under Coverage with Evidence Development for all oncology indications for FDG-PET imaging, and revise the National Coverage Determination for PET scans.

BOSTONAt Moffitt Cancer Center in Tampa, Fla., the goal is to follow patients over time, said medical oncologist William S. Dalton, PhD, MD, speaking during the Medicine 2.0 Congress. Longitudinal data combined with recognition of the uniqueness of every patient, help clinicians match the right patient to the right treatment, he said.

GE Healthcare has partnered with RadNet, a network of outpatient diagnostic imaging centers, to pilot its Best Pathways initiative, a breast cancer detection model.

BOSTONWith 50,000 pages of content on the National Cancer Institute's cancer.gov website, shaping the organization's mobile strategy was no easy task. Jonathan Cho, chief of communications technology for the National Cancer Institute, discussed the process during the Medicine 2.0 Congress.

The FDA has approved the somo-v Automated Breast Ultrasound System for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.

Beth Israel Deaconess Medical Center in Boston has purchased four Carestream DRX-Revolution mobile x-ray systems for multiple intensive care units serving trauma, cardiac, surgical and other critical care patients.

The FDA has granted 510(k) clearance for the thoracic-length HeliFX aortic securement system, an updated system to the one cleared in November 2011 to treat abdominal aortic aneurysms. The new system has a longer delivery device with additional tip configurations to bring the helical EndoAnchor technology to the treatment of thoracic aortic aneurysms (TAA).

Massachusetts Eye and Ear Infirmary and its affiliated physician group, Massachusetts Eye and Ear Associates, will pay $1.5 million to settle a HIPAA security-rule violation case.